Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 22.52 Delayed Data As of May 26 |  +0.14 / +0.63%Today’s Change | 14.89 Today|||52-Week Range 30.22 | -2.93% Year-to-Date |
Latest COLL News | Press Releases
No recent news for Collegium Pharmaceutical Inc.
Today’s Trading
| Previous close | 22.38 |
| Today’s open | 22.48 |
| Day’s range | 22.28 - 22.72 |
| Volume | 4,325 |
| Average volume (3 months) | 418,056 |
| Market cap | $779.1M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -136.11% |
| Earnings growth (this year) | +33.84% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | +67.56% |
| P/E ratio | NM |
| Price/Sales | 1.69 |
| Price/Book | 3.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QTRXQuanterix Corp | +0.02 | +0.10% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | $1.23 |
| Annual revenue (last year) | $463.9M |
| Annual profit (last year) | -$25.0M |
| Net profit margin | -5.39% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Stoughton, Massachusetts |
Forecasts
